BHE13702645
Unlike most of the synaptotagmins, SYT13 does not have an N-terminal transmembrane region. Its C2 domains are lacking almost all the residues involved in Ca2+ binding. It is highly expressed in brain and also detectable at lower levels in non-neuronal tissues. SYT13 can suppress liver tumour cells and this function may be mediated through pathways implicated in mesenchymal to epithelial transition. It also affects insulin secretion.
Contact us to order
Tel
+1 866.986.9598
Abbkine Scientific Co., Ltd.
view supplier detailsCredit card payments now incur a 3% fee.